Literature DB >> 36157095

The Pulmonary Embolism Response Team: Rationale, Operation, and Outcomes.

James J Glazier1,2, Skarlet Patiño-Velasquez1, Carlos Oviedo1.   

Abstract

The pulmonary embolism response team (PERT) is an institutionally based multidisciplinary team that is able to rapidly assess and provide treatment for patients with acute pulmonary embolism (PE). Intrinsic to the team's structure is a formal mechanism to execute a full range of medical, endovascular, and surgical therapies. In addition, the PERT provides appropriate multidisciplinary follow-up of patients. In the 10 years since the PERT was first introduced, it has gained acceptance in many centers in the United States and around the world. These PERTs have joined together to form an international association, called the PERT Consortium. The mission of this consortium is to advance the diagnosis, treatment, and outcomes of patients with PE. There is considerable evidence that the PERT model improves delivery and standardization of care of PE patients, particularly those patients with massive and submassive PE. However, it is not yet clear whether PERTs improve clinical outcomes. A large prospective database is currently being compiled by the PERT Consortium. Analysis of this database will likely further delineate the role of PERTs in the management of intermediate-to-high risk PE patients and, importantly, help determine in which PE patients PERT may improve clinical outcomes. International College of Angiology. This article is published by Thieme.

Entities:  

Keywords:  interventional cardiology; interventional radiology; multidisciplinary approach; pulmonary embolism response team; pulmonary embolus; rapid response team

Year:  2022        PMID: 36157095      PMCID: PMC9507552          DOI: 10.1055/s-0042-1750328

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  16 in total

1.  Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.

Authors:  Michael R Jaff; M Sean McMurtry; Stephen L Archer; Mary Cushman; Neil Goldenberg; Samuel Z Goldhaber; J Stephen Jenkins; Jeffrey A Kline; Andrew D Michaels; Patricia Thistlethwaite; Suresh Vedantham; R James White; Brenda K Zierler
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

Review 2.  Rapid-response teams.

Authors:  Daryl A Jones; Michael A DeVita; Rinaldo Bellomo
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

3.  RESPONSE: Do Pulmonary Embolism Response Teams Result in Improved Outcomes in Patients With Pulmonary Embolism?

Authors:  Jeffrey W Olin
Journal:  J Am Coll Cardiol       Date:  2021-04-06       Impact factor: 24.094

4.  Pulmonary Embolism Response Team: Additional Call Burden or a Valuable Learning Opportunity?

Authors:  Yevgeniy Brailovsky; Vladimir Lakhter
Journal:  J Am Coll Cardiol       Date:  2021-04-06       Impact factor: 24.094

5.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors:  Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal:  Chest       Date:  2016-01-07       Impact factor: 9.410

6.  Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.

Authors:  Connie W Tsao; Aaron W Aday; Zaid I Almarzooq; Alvaro Alonso; Andrea Z Beaton; Marcio S Bittencourt; Amelia K Boehme; Alfred E Buxton; April P Carson; Yvonne Commodore-Mensah; Mitchell S V Elkind; Kelly R Evenson; Chete Eze-Nliam; Jane F Ferguson; Giuliano Generoso; Jennifer E Ho; Rizwan Kalani; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Deborah A Levine; Tené T Lewis; Junxiu Liu; Matthew Shane Loop; Jun Ma; Michael E Mussolino; Sankar D Navaneethan; Amanda Marma Perak; Remy Poudel; Mary Rezk-Hanna; Gregory A Roth; Emily B Schroeder; Svati H Shah; Evan L Thacker; Lisa B VanWagner; Salim S Virani; Jenifer H Voecks; Nae-Yuh Wang; Kristine Yaffe; Seth S Martin
Journal:  Circulation       Date:  2022-01-26       Impact factor: 39.918

7.  Impact of Multidisciplinary Pulmonary Embolism Response Team Availability on Management and Outcomes.

Authors:  Pulkit Chaudhury; Shruti Kumar Gadre; Erika Schneider; Rahul D Renapurkar; Marcelo Gomes; Ihab Haddadin; Gustavo A Heresi; Michael Z Tong; John R Bartholomew
Journal:  Am J Cardiol       Date:  2019-08-07       Impact factor: 2.778

8.  Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis.

Authors:  Rachel Rosovsky; Yuchiao Chang; Kenneth Rosenfield; Richard Channick; Michael R Jaff; Ido Weinberg; Thoralf Sundt; Alison Witkin; Josanna Rodriguez-Lopez; Blair A Parry; Savannah Harshbarger; Praveen Hariharan; Christopher Kabrhel
Journal:  J Thromb Thrombolysis       Date:  2019-01       Impact factor: 2.300

9.  Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team.

Authors:  Brett J Carroll; Sebastian E Beyer; Tyler Mehegan; Andrew Dicks; Abby Pribish; Andrew Locke; Anuradha Godishala; Kevin Soriano; Jaya Kanduri; Kelsey Sack; Inbar Raber; Cara Wiest; Isabel Balachandran; Mason Marcus; Louis Chu; Margaret M Hayes; Jeff L Weinstein; Kenneth A Bauer; Eric A Secemsky; Duane S Pinto
Journal:  Am J Med       Date:  2020-05-19       Impact factor: 4.965

10.  Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium.

Authors:  Belinda Rivera-Lebron; Michael McDaniel; Kamran Ahrar; Abdulah Alrifai; David M Dudzinski; Christina Fanola; Danielle Blais; David Janicke; Roman Melamed; Kerry Mohrien; Elizabeth Rozycki; Charles B Ross; Andrew J Klein; Parth Rali; Nicholas R Teman; Leoara Yarboro; Eugene Ichinose; Aditya M Sharma; Jason A Bartos; Mahir Elder; Brent Keeling; Harold Palevsky; Soophia Naydenov; Parijat Sen; Nancy Amoroso; Josanna M Rodriguez-Lopez; George A Davis; Rachel Rosovsky; Kenneth Rosenfield; Christopher Kabrhel; James Horowitz; Jay S Giri; Victor Tapson; Richard Channick
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.